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Abstract
 Background—GlycA is a novel serum marker of systemic inflammation. There is no 
information on GlycA in pediatric populations, how it differs by gender or its association with 
body mass index (BMI) or fitness. LP-IR is a serum measure of insulin resistance which is related 
to changes in BMI group in adolescents, but its relationship with fitness is unknown. The current 
study examined the independent associations between fitness and BMI with GlycA and LP-IR 
among US adolescents.
 Methods—Participants were 1664 US adolescents from the HEALTHY study with complete 
6th and 8th grade BMI, fitness and blood data. GlycA and LP-IR were measured by NMR 
spectroscopy. Three BMI groups and three fitness groups were created. Linear mixed models 
examined associations between GlycA, LP-IR, fitness and BMI.
 Results—LP-IR decreased between 6th and 8th grade. GlycA increased among girls but 
decreased among boys. At 8th grade, median GlycA values were 27 (7.6%) μmol/L higher (381 
versus 354) for girls than boys. Median GlycA 6th grade values were 9% higher in obese girls than 
healthy weight girls. Overall there was strong evidence (p<0.001) that GlycA was higher in higher 
BMI groups. Fitness was negatively associated with GlycA (r = −0.37 and −0.35) and LP-IR (r = 
−0.34 and − 0.18) at the 6th and 8th grade assessments. As BMI category increased and fitness 
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category decreased, GlycA and LP-IR levels increased. Lowest GlycA was found in the low BMI/
high fitness group.
 Conclusions—GlycA was associated with BMI and fitness among in US adolescents. These 
findings suggest that there are independent effects for BMI and fitness group with both GlycA and 
LP-IR. Future studies should validate the role of GlycA and LP-IR to evaluate the effects of 
interventions to modify obesity and fitness in order to improve systemic inflammation and insulin 
resistance.
 INTRODUCTION
Obesity and low levels of cardio-respiratory fitness (fitness) are associated with the 
development of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM)1–3. The 
physiological mechanisms that contribute to these well established associations are 
dyslipidemia, insulin resistance and inflammation all of which are associated with obesity 
and low fitness4–7. A number of studies have demonstrated the adverse effects of increased 
body fat and low fitness in childhood on future health, with childhood obesity being strongly 
associated with its persistence into adulthood and fitness tracking through childhood into the 
adulthood8–10. A number of adult studies have suggested that there are independent 
associations between fitness and body mass index in relation to the risk of cardiovascular 
disease, type 2 diabetes and all-cause mortality1, 2. C-reactive protein (CRP), a marker of 
systemic inflammation and predictor of cardiovascular risk, has been shown to be closely 
associated with obesity among children and adults11. Thus, there is a need to examine how 
various relevant metabolic markers, such as dyslipidemia, insulin resistance and 
inflammation are associated with body mass and fitness among children. A key issue is 
whether there are associations between markers of dyslipidemia, insulin resistance and 
inflammation with body mass and fitness in pediatric populations. If associations exists 
these markers could be considered potential targets for the reduction of future cardiovascular 
disease risk.
GlycA, a novel composite measure of systemic inflammation, and the lipoprotein insulin 
resistance index (LP-IR) are promising new clinical biomarkers measured by nuclear 
magnetic resonance (NMR) spectroscopy12, 13. Both are obtained efficiently and 
inexpensively from the same NMR LipoProfile test spectra acquired on automated clinical 
NMR analyzers to quantify lipoprotein particles for use in CVD risk management14. Several 
recent reports have appeared relating these new markers to CVD and T2DM risk in 
adults15, 16, but no comparable data are available in children and adolescents.
Clinical interest in GlycA stems partly from its composite nature, reflecting the integrated 
concentrations and glycosylation states of several of the most abundant acute-phase proteins 
in serum, and its much lower intra-individual biological variability compared to CRP and 
other markers of inflammation12. As a result, GlycA may provide a more stable measure of 
low-grade systemic inflammation that responds more consistently to diverse inflammatory 
stimuli than individual acute-phase reactants such as CRP. In several adult studies, GlycA 
and CRP were found to have independent associations with incident CVD of comparable 
strength, with some evidence of complementarity suggesting a possible adjunctive clinical 
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use17–20. Similar observations were made relating GlycA to prediction of future T2DM in 
the Women’s Health Study and Dutch PREVEND study15, 16.
The insulin resistance biomarker, LP-IR, reflects the lipoprotein derangements of insulin 
resistance and is derived by combining 6 NMR measures of very-low-density lipoprotein 
(VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particle size 
and subclass concentration13. Each of these subclass and size parameters has been shown 
individually to be associated with incident T2DM in the Women’s Health Study21, and the 
composite LP-IR score exhibited robust diabetes prediction in a large multi-ethnic cohort of 
men and women22.
We previously obtained NMR LipoProfile spectra from a substantial subset of 6th and 8th 
grade participants in the ethnically diverse HEALTHY trial, initially to characterize the 
differences between NMR-measured lipoprotein particle numbers and traditional lipid 
measures in a large pediatric population23. In a subsequent report, changes in relative weight 
group from 6th to 8th grade were related to lipoprotein particle changes associated with risk 
of CVD and T2DM, as well as alterations in insulin resistance assessed by LP-IR and insulin 
and glucose measurements24. In this paper, we take advantage of the ability, with newly 
available software, to extract GlycA values from the same NMR LipoProfile dataset to 
address the absence of information in youth regarding relations of body weight and fitness 
with GlycA and LP-IR. The aims of this study in an ethnically diverse sample of children 
were to: a) report on levels of GlycA and the change in GlycA as children move from 6th to 
8th grade; b) examine whether BMI group is associated with GlycA in these children; c) 
determine if fitness was associated with GlycA, LP-IR and traditional lipid panel variables; 
and d) examine whether fitness and BMI are independently related to GlycA and/or LP-IR.
 METHODS
The analyses reported in this paper used information from stored blood from the HEALTHY 
Study, a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) cluster 
randomized controlled trial that aimed to reduce the prevalence of risk factors for type 2 
diabetes mellitus among middle school children (6th – 8th grade)25, 26. Details of the study 
design and results have been reported in a number of publications25, 26. Briefly, the study 
was conducted in 42 middle schools across the US. In order to participate in the study, 
schools had to have at least 50% of students eligible for free or reduced-price lunch or 
belonging to an ethnic minority group at increased risk of type 2 diabetes. The intervention 
had several components including changes to the physical education and cafeteria programs 
as well as health education and a school wide social marketing campaign25, 27–32. The study 
was approved by the Institutional Review Boards at each field center and written parental 
consent and childhood assent was obtained from all participants33. The sample for this study 
is limited to the 1664 participants who provided parental consent/child assent for ancillary 
analyses of stored blood, and for whom complete data were available.
 Procedures
All measures were assessed at baseline (beginning of 6th grade) and follow-up (end of 8th 
grade). Pubertal status was self-reported using the Pubertal Development Scale34 and 
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converted to pubertal stage groups consistent with the five pubertal stages outlined by 
Tanner35. Household education were determined from parental report and gender and race/
ethnicity was self-reported. Height and body mass were measured without shoes using the 
Prospective Enterprises PE-AIM-101 stadiometer and the SECA Corporation Alpha 882 
electronic scale. Body Mass Index (kg/m2) was calculated and converted to an age and 
gender specific BMI percentile using CDC 2000 criteria36. For descriptive purposes 
participants with a BMI <85th percentile were classified as healthy weight; while BMI ≥85th 
percentile but <95th percentile were classified as overweight and those with BMI ≥95th 
percentile were classified as obese.
Cardiorespiratory fitness was assessed using the 20-meter shuttle test (20-MST)37, 38 during 
a Physical Education class. The test required students to run back and forth between two 
lines set 20 meters apart. The running pace was determined by audio signals emitted from a 
pre-recorded CD. The test started at 8.5 km/hr and increased by 0.5 km/hr with each 
subsequent level. The test was completed when the participant was not able to complete the 
distance at the stipulated pace on two laps.
Fasting blood samples were collected from all participants. Standard lipid profiles including 
HDL-C were measured by CDC-standardized direct assay at the University of 
Washington39. LDL-C was calculated using the Friedewald equation40. Insulin was 
measured by a two-site immuno-enzymometric assay41. Fasting insulin (performed using a 
Tosoh 1800 auto-analyzer) and glucose (performed on a Roche P module auto-analyzer by 
the hexokinase method) were used to calculate the homeostatic model assessment of insulin 
resistance (HOMA-IR) according to the formula: Glucose*Insulin/[μU/L] 22.542. 
Lipoprotein particle profiles were measured by NMR spectroscopy with the LipoProfile-3 
algorithm at LipoScience, Inc (Raleigh, NC) on frozen EDTA plasma specimens and LP-IR 
and GlycA were derived using previously published procedures12, 13
 Statistical analysis
Overall, 2367 participants in HEALTHY had samples analyzed by LipoScience. Of these, 
703 were excluded from the present analysis, most due to imprecise classification of their 
race or the lack of either a 6th or 8th grade fitness test. Descriptive statistics, including 
means, standard deviations, and percentages were calculated for those included and excluded 
from the analysis. Differences between those included and excluded were tested using a 
generalized linear mixed model which took into account the sources of variability within and 
between schools. A similar approach was undertaken for baseline characteristics of the 
analysis sample to examine gender differences.
Measures in 6th grade, 8th grade and change between 6th and 8th grade are summarized using 
mean and 95% confidence interval for normally distributed measures (number of laps) and 
medians and interquartile range (IQR) for parameters not fitting a normal distribution (lipid 
measures, insulin resistance measures and GlycA) by gender. Median and IQR are also 
presented for GlycA based on BMI category for normal weight (BMI < 85th percentile), 
overweight (BMI 85th to 94th percentile) and obese (BMI ≥ 95th percentile) and percentiles 
were calculated by gender and grade for GlycA.
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Generalized linear mixed models were constructed to examine the association between 
GlycA and BMI category for 6th grade and 8th grade (adjusting for GlycA in 6th grade), 
separately for girls and boys taking into account the sources of variability within and 
between schools. These models were adjusted for race/ethnicity, highest household 
education, intervention group with the 6th grade models also adjusted for 6th grade Tanner 
stage and the 8th grade models adjusted for 8th grade Tanner stage and 6th grade GlycA 
value. Spearman correlations between GlycA and lipid measures, insulin resistance, BMI 
percentile, and fitness (number of laps) were calculated for 6th grade and 8th grade with both 
genders combined since there were no appreciable differences between the genders. The 
analysis of the 8th grade data, which is adjusted for 6th grade values, allows us to account for 
the longitudinal nature of the data.
Level of fitness was classified into quartiles by grade and gender and then further classified 
as low, medium or high fitness levels. Low fitness level was defined to be those grouped into 
the first quartile: 6th grade girls 0–11 laps, 6th grade boys 0–12 laps, 8th grade girls 1–12 
laps, 8th grade boys 1–17 laps. Medium fitness level was defined to be those grouped into 
the second or third quartile: 6th grade girls 12–23 laps, 6th grade boys 13–30 laps, 8th grade 
girls 13–26 laps, 8th grade boys 18–44 laps. Finally, high fitness was defined as those 
grouped into the fourth quartile: 6th grade girls 24–57 laps, 6th grade boys 31–75 laps, 8th 
grade girls 27–79 laps, 8th grade boys 45–103 laps. Adjusted means and standard errors 
were then computed for GlycA, LP-IR, LDL-P and non-HDL-C within BMI classification 
(normal, overweight, obese) and fitness level. Levels of GlycA, LP-IR, LDL-P and non-
HDL-C were then categorized within the three BMI and three fitness groups to create nine 
subgroups and these groups were tabulated by gender at both 6th and 8th grade. To further 
facilitate understanding, the GlycA and LP-IR values in these subgroups were then 
presented graphically.
All p-values reported within this paper represent findings associated with secondary 
outcomes from a large cluster randomized controlled trial and these hypotheses were not 
pre-specified in the trial design. As such, p-values are provided to help facilitate the 
interpretation of the data only. SAS 9.3 statistical software (SAS Institute, Cary, NC) was 
used for analyses.
 RESULTS
Descriptive statistics for 6th grade participants are presented overall and by gender in Table 
1. The data in Table 1 present strong evidence that boys recorded a higher number of shuttle 
run laps than the girls (23.1 versus 18.5, p<0.001) and some evidence that boys had a higher 
BMI percentile (75.4 versus 72.4, p = 0.0264) than the girls.
Supplemental Table A provides descriptive information on the participants included and 
excluded from the analyses. These data provide some evidence (p = 0.0043) that there was a 
difference in the ethnicity of the included versus excluded participants with higher 
proportions of Hispanic (62.7% vs. 40.4%) and White participants (20.7% vs. 12.2%) in the 
included sample.
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Table 2 provides descriptive information (means and 95% CI or median and inter-quartile 
range) for fitness, lipids, insulin resistance and GlycA variables at 6th and 8th grade along 
with the temporal changes (8th – 6th grade value) stratified by gender. The table shows that 
among both girls and boys non-HDL-C, LDL-C and LP-IR decreased between 6th and 8th 
grade while HOMA-IR increased. GlycA increased by 16 μmol/L (3.8% based on medians) 
among girls but decreased by 6 μmol/L (3.1% based on medians) among the boys. At 8th 
grade the median GlycA values were 27 (7.6%) μmol/L higher (381 versus 354) for girls 
than boys. Supplementary Table B provides percentiles of GlycA by grade and gender.
Supplementary Table C provides the medians and inter-quartile ranges for GlycA by BMI 
group stratified by gender and grade level. The median GlycA value for 6th grade obese girls 
was 417 μmol/L compared to 351 for healthy weight girls, and as such, GlycA levels are 
19% higher in obese girls than healthy weight girls. The data in the table provide strong 
evidence (p<0.001) that in all sub-groups GlycA is higher in higher BMI groups. 
Supplementary Table D provides Spearman correlations between all of the variables. The 
number of shuttle run laps is negatively associated with GlycA (r = −0.37 and r = −0.35) and 
LP-IR (r = −0.34 and r = −0.18) for the 6th and 8th grade associations respectively.
Figure 1 provides a graphical presentation of levels of adjusted GlycA by BMI and fitness 
categories stratified by gender and 6th or 8th grade. The figure demonstrates that across all 
four sub-groups there is evidence that as BMI category increases and fitness category 
decreases levels of GlycA increase. Furthermore, in all four sub-groups the lowest levels of 
GlycA are in the low BMI/high fitness group with the highest levels in the high BMI/low 
fitness group. Comparable patterns are also evident for LP-IR levels, which are graphically 
presented in Figure 2. The data used to create Figures 1 and 2 are available in 
Supplementary Table E.
 DISCUSSION
This study is the first to provide descriptive information on levels of GlycA, a new NMR-
derived marker of systemic inflammation, in adolescents. The data presented in this study 
have shown, in an ethnically diverse sample of adolescents, that GlycA is associated with 
BMI group with levels of GlycA higher across BMI groups among both boys and girls in the 
6th and 8th grades. These data also show that GlycA is inversely correlated with shuttle run 
laps, a surrogate measure of cardiorespiratory fitness at both 6th and 8th grade. Furthermore, 
when levels of GlycA were analyzed by the three BMI and three fitness groups there is 
evidence of a relationship between fitness, BMI group and GlycA with the highest levels of 
GlycA among obese children in the lowest fitness category. The relationship between fitness, 
BMI and GlycA was similar for both boys and girls at 6th and 8th grade. A key finding of 
this study is therefore that GlycA, a new measure of systemic inflammation, is associated 
with both body mass and fitness in a pediatric population. As such, further examination of 
GlycA in pediatric populations is warranted to identify associations with future disease risk 
and the response to changes in fitness and body mass among children.
There was evidence that LP-IR was negatively correlated with the number of shuttle laps run 
at both 6th and 8th grade. We have previously reported that LP-IR is associated with BMI 
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group and change in BMI group among boys and girls in the same sample24. Thus, in this 
paper we have extended these findings by showing that there are independent effects of 
fitness and BMI group on LP-IR with the lowest levels of LP-IR among the low BMI/high 
fitness group and the highest levels among the high BMI/low fitness group. These patterns 
were comparable among boys and girls at 6th and 8th grade. These finding therefore suggest 
that facilitating increased fitness and lower BMI is likely to be important for achieving lower 
levels of LP-IR among adolescents, which may reduce overall CVD risk.
The association reported in this paper between fitness, BMI and GlycA is broadly consistent 
with previous research, which has shown that fitness is associated with CRP, another 
measure of systemic inflammation, after accounting for body mass. For example, in a cross-
sectional analysis, the fitness levels of young adults were inversely associated with CRP and 
this association was maintained even after adjustment for body mass index43. Similarly, 
among adults with type 2 diabetes a change in fitness over 12-months was associated with 
change in CRP and this association was independent of BMI change44. In adolescents, 
fitness and fatness (assessed via skinfolds) have been were independently associated with 
systemic inflammation, as measured by CRP45. There is some evidence that GlycA may be a 
better marker of shorter-term CVD risk (events occurring within ~6 years) than longer-term 
risk which may mean that GlycA can serve as an early marker of adult disease risk but it is 
not currently clear if this is the case for adolescents17. However, GlycA has a lower level of 
intra-individual variability than CRP which might make it attractive as a CVD risk marker 
across time. As CRP was not available in the HEALTHY study, it is not possible to directly 
compare the associations between CRP and GlycA, fitness and BMI group in this dataset. As 
such, we are unable to state that one biomarker may be preferable to another, but such an 
assessment in a future study is warranted. Moreover, it would be useful to assess whether 
intervention studies that target increased fitness and reduced body mass might yield 
improvements in GlycA.
Higher levels of cardio-respiratory fitness have been associated with a reduced risk of 
developing cardiovascular disease and type 2 diabetes among adults1, 2. For example, recent 
analysies of the CARDIA study have shown that fitness in young adulthood was associated 
with all-cause mortality approximately 27 years later with each additional minute of exercise 
test duration associated with a 15% lower hazard of death3. Interestingly the study showed 
that CRP was much higher in the low fitness group, thereby highlighting the important link 
between fitness and inflammation. The current study extends this work to show how fitness 
and obesity are independently associated with GlycA, a novel measure of systemic 
inflammation in a pediatric population.
GlycA levels were 7% higher for girls than boys at 8th grade but were comparable between 
the genders in 6th grade. This finding is broadly consistent with the adult literature in which 
CRP levels are higher among women than men46, 47 despite the lack of a difference in 
absolute or relative risk of cardiovascular events when compared to men48. We presume that 
this gender difference may represent a hormonal influence upon GlycA, which is 
independent of its role as a CVD risk marker. The emergence of higher levels of GlycA in 
8th grade girls, therefore, might be expected with the progression of puberty, generally 
occurs between 6th and 8th grade in girls. For example, in this study the proportion of girls 
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classified as Tanner Stage 4 or 5 at 6th grade was 23.5% but by 8th grade this had increased 
to 94.2%. As previous research has shown that the advancement of puberty is associated 
with changes in insulin sensitivity49 it may also be the case that pubertal hormones exert 
more direct effects on systemic inflammation, and this influence may persist beyond 
puberty. Further research into hormonal influences on these markers of inflammation is 
therefore warranted.
 Strengths/limitations
The major strength of this study is the provision of a detailed analysis of GlycA and LP-IR 
in a large, ethnically diverse sample of young people progressing from 6th to 8th grade. No 
comparable data exist and as such these data make a unique contribution to the field. 
However, the study has several limitations to be considered. Firstly, a field based measure of 
fitness (shuttle run laps) was used in the analyses. Although this measure has been shown to 
be closely correlated with directly measured oxygen uptake it is less precise than laboratory 
based methods50–52. Secondly, we used a self-report measure for assignment of pubertal 
status. Although this measure has been validated, it is not generally considered to be as 
reliable as clinician assessment of Tanner staging34. Thirdly, the analyses in this paper have 
focused on GlycA, a new measure of systemic inflammation, but as CRP is not available in 
this dataset it is not possible to assess how associations may compare to the more widely 
used marker of systematic inflammation. Fourth, it is important to recognize that the 
analyses reported in this paper were conducted on a sub-set of participants who provided 
consent for ancillary analyses and complete data for all variables were available. In 
particular, the observed difference in the ethnicity of the included versus the excluded 
participants is a potential weakness. Fifth, it is important to note that consistent with other 
studies1, 2 that have examined the association between fitness, body mass and health 
outcomes we have only assessed and analyzed cardio-vascular fitness and have no data to 
comment on broader aspects of fitness such as strength. Finally, this is a post hoc analysis of 
secondary endpoints and our analyses have not been corrected for the multiple comparisons 
being made, and should therefore be regarded as exploratory.
 CONCLUSIONS
GlycA, a new measure of systemic inflammation, was associated with BMI and fitness 
among an ethnically diverse sample of adolescents in the US. Analyses also provided 
evidence of independent effects for BMI and fitness groups when related to both GlycA and 
LP-IR, a multivariate insulin resistance score. These findings suggest that reducing body 
mass and increasing fitness may reduce both systemic inflammation (GlycA) and insulin 
resistance (LP-IR). Further examination of how body mass, fitness and changes in both of 
these health indicators is associated with GlycA in pediatric populations is therefore 
warranted.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Inflammation (GlycA) in Obesity and Fitness Subgroups
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Figure 2. 
Insulin Resistance (LP-IR) in Obesity and Fitness Subgroups
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